PRLD / Prelude Therapeutics Incorporated - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Prelude Therapeutics Incorporated
US ˙ NasdaqGS ˙ US74065P1012

Jumlah Saham Beredar 43,750,086 shares
Saham Orang Dalam35,531,914 shares
Kepemilikan oleh Orang Dalam81.22 %
Orang Dalam Sejati21
Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.

Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan akumulasi orang dalam tertinggi.

Skor Sentimen Petugas

Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.

Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.

Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan sentimen orang dalam tertinggi.

Metrik Utama Orang Dalam

Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.

Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).

Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)

0 ( )

1596 out of 11305

Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).

Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)

0.000 %( )

1589 out of 11224

Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.

Grafik Perdagangan Orang Dalam

Grafik berikut menunjukkan Prelude Therapeutics Incorporated transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.

Daftar Orang Dalam dan Metrik Profitabilitas

Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Baker Bros. Advisors Lp Director, 10% Owner - [D] [10%] 9,252,951 9,252,951
Julian Baker Director, 10% Owner - [D] [10%] 9,252,951 9,252,951
Martin Babler 36,400
David P Bonita Director, 10% Owner - [D] [10%] 10,646,056 10,646,056
Laurent Chardonnet Chief Financial Officer - [O] 42,165 42,165
Andrew Combs Chief Chemistry Officer - [O] 480,123 480,123
Mardi Dier Director - [D] 10,000 10,000
Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Paul A Friedman Director - [D] 500,098 500,098
Jane Huang President, CMO - [O] 80,897 80,897
Bryant David Lim CLO, Interim CFO, Corp Sec. - [O] 27,400 27,400
David J Mauro Chief Medical Officer - [O] 0 0
Deborah Morosini EVP, Chief of Clinical Affairs - [O] 444 444
Kelvin Neu 0
Orbimed Advisors Llc Director, 10% Owner - [D] [10%] 10,646,056 10,646,056
Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Orbimed Capital Llc Director, 10% Owner - [D] [10%] 5,596,886 10,646,056
OrbiMed Capital GP VI LLC Director, 10% Owner - [D] [10%] 5,596,886 10,646,056
Christopher Pierce EVP and Chief of Business Oper - [O] 3,750 3,750
Brian Piper Chief Financial Officer - [O] 0 0
Victor Sandor 11,206
Peggy Scherle Chief Scientific Officer - [O] 172,920 172,920
Krishna Vaddi CEO, Director - [D] [O] 3,669,054 3,669,054

Report errors via our new Insider Auditing Tool

Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di PRLD / Prelude Therapeutics Incorporated. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2025-03-25 Combs Andrew 100,000 0.6925 100,000 0.6925 69,250 156 1.3100 61,750 89.17
2025-03-25 Vaddi Krishna 675,000 0.6925 675,000 0.6925 467,438
2025-03-21 Vaddi Krishna 15,000 0.7306 15,000 0.7306 10,959
2025-03-20 Vaddi Krishna 5,416 0.7294 5,416 0.7294 3,950
2025-03-17 Vaddi Krishna 9,106 0.7499 9,106 0.7499 6,829
2025-03-14 Vaddi Krishna 29,999 0.7544 29,999 0.7544 22,631
2025-03-13 Vaddi Krishna 50,000 0.7164 50,000 0.7164 35,820
2025-03-12 Vaddi Krishna 47,500 0.7104 47,500 0.7104 33,744
2024-12-31 Vaddi Krishna 5,000 1.2087 5,000 1.2087 6,044

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

PRLD / Prelude Therapeutics Incorporated Insider Trades
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di PRLD / Prelude Therapeutics Incorporated. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2023-04-06 Huang Jane 13,280 6.1200 13,280 6.1200 81,274 208 1.6900 -58,830 -72.39

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

PRLD / Prelude Therapeutics Incorporated Insider Trades
Riwayat Transaksi

Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.

Berkas
Tanggal
Perdagangan
Tanggal
Formulir Orang Dalam Ticker Judul Keamanan Kode 10b5-1 Langsung Latihan
Harga
Satuan
Harga
Unit
Diubah
Nilai
Diubah (1 ribu)
Sisa
Pilihan
Sisa
Saham
2025-07-08 2025-07-04 4 Huang Jane PRLD Common Stock F - Taxes D 0.7939 -3,355 -3 80,897
2025-07-08 2025-07-04 4 Huang Jane PRLD Common Stock M - Exercise D 9,375 84,252
2025-04-07 2025-04-04 4 Huang Jane PRLD Common Stock F - Taxes D 0.6750 -3,355 -2 74,877
2025-04-07 2025-04-04 4 Huang Jane PRLD Common Stock M - Exercise D 9,375 78,232
2025-03-27 2025-03-25 4 Combs Andrew PRLD Common Stock P - Purchase D 0.6925 100,000 69 480,123
2025-03-27 2025-03-25 4 Vaddi Krishna PRLD Common Stock P - Purchase D 0.6925 675,000 467 1,999,296
2025-03-24 2025-03-21 4 Vaddi Krishna PRLD Common Stock P - Purchase D 0.7306 15,000 11 1,324,296
2025-03-24 2025-03-20 4 Vaddi Krishna PRLD Common Stock P - Purchase D 0.7294 5,416 4 1,309,296
2025-03-18 2025-03-17 4 Vaddi Krishna PRLD Common Stock P - Purchase D 0.7499 9,106 7 1,303,880
2025-03-18 2025-03-14 4 Vaddi Krishna PRLD Common Stock P - Purchase D 0.7544 29,999 23 1,294,774
2025-03-14 2025-03-13 4 Vaddi Krishna PRLD Common Stock P - Purchase D 0.7164 50,000 36 1,264,775
2025-03-14 2025-03-12 4 Vaddi Krishna PRLD Common Stock P - Purchase D 0.7104 47,500 34 1,214,775
2025-01-07 2025-01-04 4 Huang Jane PRLD Common Stock F - Taxes D 1.3900 -3,859 -5 68,857
2025-01-07 2025-01-04 4 Huang Jane PRLD Common Stock M - Exercise D 9,375 72,716
2025-01-03 2024-12-31 4 Vaddi Krishna PRLD Common Stock P - Purchase I 1.2087 5,000 6 142,553
2025-01-02 2024-12-30 4 Vaddi Krishna PRLD Common Stock P - Purchase I 1.2000 10,000 12 137,553
2024-12-26 2024-12-23 4 Combs Andrew PRLD Common Stock P - Purchase D 1.3667 60,000 82 377,623
2024-12-26 2024-12-20 4 Combs Andrew PRLD Common Stock P - Purchase D 1.1500 3,075 4 317,623
2024-12-20 2024-12-19 4 Lim Bryant David PRLD Common Stock P - Purchase D 0.9055 25,000 23 27,400
2024-12-20 2024-12-19 4 Vaddi Krishna PRLD Common Stock P - Purchase I 0.8879 6,888 6 127,553
2024-12-20 2024-12-18 4 Vaddi Krishna PRLD Common Stock P - Purchase D 0.9321 100,000 93 1,167,275
2024-10-07 2024-10-04 4 Huang Jane PRLD Common Stock F - Taxes D 2.0000 -3,349 -7 63,341
2024-10-07 2024-10-04 4 Huang Jane PRLD Common Stock M - Exercise D 9,375 66,690
2024-07-08 2024-07-04 4 Huang Jane PRLD Common Stock F - Taxes D 3.6000 -3,347 -12 57,315
2024-07-08 2024-07-04 4 Huang Jane PRLD Common Stock M - Exercise D 9,375 60,662
2024-04-08 2024-04-04 4 Huang Jane PRLD Common Stock F - Taxes D 4.7400 -3,347 -16 51,287
2024-04-08 2024-04-04 4 Huang Jane PRLD Common Stock M - Exercise D 9,375 54,634
2024-01-08 2024-01-04 4 Huang Jane PRLD Common Stock F - Taxes D 3.7700 -3,844 -14 45,259
2024-01-08 2024-01-04 4 Huang Jane PRLD Common Stock M - Exercise D 9,375 49,103
2023-10-06 2023-10-04 4 Huang Jane PRLD Common Stock M - Exercise D 9,375 39,728
2023-07-06 2023-07-04 4 Huang Jane PRLD Common Stock F - Taxes D 4.6500 -3,242 -15 30,353
2023-07-06 2023-07-04 4 Huang Jane PRLD Common Stock M - Exercise D 9,375 33,595
2023-05-26 2023-05-25 4 Vaddi Krishna PRLD Common Stock P - Purchase D 5.3100 900 5 1,067,275
2023-05-26 2023-05-24 4 Vaddi Krishna PRLD Common Stock P - Purchase D 5.0114 1,000 5 1,066,375
2023-05-25 2023-05-23 4 Chardonnet Laurent PRLD Common Stock P - Purchase D 5.5000 5,000 28 42,165
2023-05-25 2023-05-24 4 Lim Bryant David PRLD Common Stock P - Purchase D 5.3900 2,400 13 2,400
2023-05-25 2023-05-23 4 Vaddi Krishna PRLD Common Stock P - Purchase D 5.6300 11,856 67 1,065,375
2023-05-24 2023-05-22 4 ORBIMED ADVISORS LLC See footnotes PRLD Common Stock P - Purchase I 5.7500 869,565 5,000 10,119,756
2023-05-24 2023-05-22 4 Bonita David P See footnotes PRLD Common Stock P - Purchase I 5.7500 869,565 5,000 10,119,756
2023-04-06 2023-04-06 4 Huang Jane PRLD Common Stock S - Sale D 6.1200 -13,280 -81 24,220
2023-04-06 2023-04-04 4 Huang Jane PRLD Common Stock M - Exercise D 37,500 37,500
2022-12-21 2022-12-20 4 Vaddi Krishna PRLD Common Stock P - Purchase I 5.1306 19,188 98 120,665
2022-12-12 2022-12-08 4 Chardonnet Laurent PRLD Common Stock P - Purchase D 4.7600 10,000 48 35,873
2022-06-01 2022-06-01 4 Chardonnet Laurent PRLD Common Stock P - Purchase D 4.2300 10,000 42 24,500
2022-05-04 2022-05-02 4 Huang Jane PRLD Restricted Stock Unit A - Award D 150,000 150,000
2022-05-04 2022-05-02 4 Huang Jane PRLD Employee Stock Option (Right to Buy) A - Award D 4.86 460,000 460,000
2022-04-04 2022-04-01 4 Combs Andrew PRLD Employee Stock Option (right to buy) M - Exercise D 1.89 -36,062 50,397
2022-04-04 2022-03-31 4 Combs Andrew PRLD Common Stock M - Exercise D 1.8900 36,062 68 304,442
2022-03-22 2022-03-21 4 Chardonnet Laurent PRLD Common Stock A - Award D 7.5100 6,500 49 14,500
2022-02-17 2022-02-15 4 Chardonnet Laurent PRLD Employee Stock Option (right to buy) A - Award D 10.58 90,000 90,000
2022-02-17 2022-02-15 4 Scherle Peggy PRLD Employee Stock Option (right to buy) A - Award D 10.58 100,000 100,000
2022-02-17 2022-02-15 4 Morosini Deborah PRLD Employee Stock Option (right to buy) A - Award D 10.58 90,000 90,000
2022-02-17 2022-02-15 4 Vaddi Krishna PRLD Employee Stock Option (right to buy) A - Award D 10.58 327,900 327,900
2022-02-17 2022-02-15 4 Combs Andrew PRLD Employee Stock Option (right to buy) A - Award D 10.58 100,000 100,000
2022-01-05 2022-01-03 4 Sandor Victor PRLD Director Stock Option (Right to Buy) A - Award D 13.22 11,206 11,206
2021-12-17 2021-12-15 4 Morosini Deborah PRLD Employee Stock Option (right to buy) M - Exercise D 12.85 -882 195,163
2021-12-17 2021-12-15 4 Morosini Deborah PRLD Employee Stock Option (right to buy) M - Exercise D 12.85 -24,853 74,575
2021-12-17 2021-12-15 4 Morosini Deborah PRLD Employee Stock Option (right to buy) M - Exercise D 1.89 -3,016 1,307
2021-12-17 2021-12-15 4 Morosini Deborah PRLD Common Stock S - Sale D 13.0000 -28,751 -374 444
2021-12-17 2021-12-15 4 Morosini Deborah PRLD Common Stock M - Exercise D 12.8500 25,735 331 29,195
2021-12-17 2021-12-15 4 Morosini Deborah PRLD Common Stock M - Exercise D 1.8900 3,016 6 3,460
2021-12-15 2021-12-14 4 Combs Andrew PRLD Common Stock P - Purchase D 11.6000 4,000 46 268,380
2021-12-15 2021-12-13 4 Combs Andrew PRLD Common Stock P - Purchase D 12.1200 4,000 48 264,380
2021-12-14 2021-12-13 4 Chardonnet Laurent PRLD Common Stock A - Award D 12.2800 5,000 61 8,000
2021-12-14 2021-12-13 4 Vaddi Krishna PRLD Common Stock A - Award D 12.1294 8,000 97 1,053,519
2021-12-01 2021-11-29 4 Chardonnet Laurent PRLD Employee Stock Option (Right to Buy) A - Award D 13.75 180,000 180,000
2021-12-01 3 Chardonnet Laurent PRLD Common Stock D 3,000
2021-11-18 2021-11-16 4 Morosini Deborah PRLD Employee Stock Option (right to buy) M - Exercise D 12.85 -28,751 196,045
2021-11-18 2021-11-16 4 Morosini Deborah PRLD Common Stock S - Sale D 16.4250 -400 -7 444
2021-11-18 2021-11-16 4 Morosini Deborah PRLD Common Stock S - Sale D 15.8711 -28,351 -450 844
2021-11-18 2021-11-16 4 Morosini Deborah PRLD Common Stock M - Exercise D 12.8500 28,751 369 29,195
2021-10-14 2021-10-13 4 Sandor Victor PRLD Director Stock Option (Right to Buy) A - Award D 15.81 8,022 8,022
2021-10-06 2021-10-05 4 Mauro David J PRLD Employee Stock Option (Right to Buy) M - Exercise D 1.89 -15,000 137,610
2021-10-06 2021-10-05 4 Mauro David J PRLD Common Stock S - Sale D 32.0637 -1,289 -41 0
2021-10-06 2021-10-05 4 Mauro David J PRLD Common Stock S - Sale D 31.3030 -7,803 -244 1,289
2021-10-06 2021-10-05 4 Mauro David J PRLD Common Stock S - Sale D 30.2577 -5,908 -179 9,092
2021-10-06 2021-10-05 4 Mauro David J PRLD Common Stock M - Exercise D 1.8900 15,000 28 15,000
2021-09-09 2021-09-07 4 Mauro David J PRLD Employee Stock Option (Right to Buy) M - Exercise D 1.89 -15,000 167,610
2021-09-09 2021-09-07 4 Mauro David J PRLD Common Stock S - Sale D 37.7876 -4,640 -175 0
2021-09-09 2021-09-07 4 Mauro David J PRLD Common Stock S - Sale D 36.9234 -2,873 -106 4,640
2021-09-09 2021-09-07 4 Mauro David J PRLD Common Stock S - Sale D 35.9112 -7,487 -269 7,513
2021-09-09 2021-09-07 4 Mauro David J PRLD Common Stock M - Exercise D 1.8900 15,000 28 15,000
2021-09-07 2021-09-02 4 Pierce Christopher PRLD Employee Stock Option (right to buy) M - Exercise D 12.85 -17,000 207,796
2021-09-07 2021-09-02 4 Pierce Christopher PRLD Common Stock S - Sale D 42.4974 -6,930 -295 3,750
2021-09-07 2021-09-02 4 Pierce Christopher PRLD Common Stock S - Sale D 41.5176 -6,727 -279 10,680
2021-09-07 2021-09-02 4 Pierce Christopher PRLD Common Stock S - Sale D 40.2922 -3,343 -135 17,407
2021-09-07 2021-09-02 4 Pierce Christopher PRLD Common Stock M - Exercise D 12.8500 17,000 218 20,750
2021-08-30 2021-08-27 4 Scherle Peggy PRLD Employee Stock Option (Right to Buy) M - Exercise D 1.43 -6,014 27,018
2021-08-30 2021-08-27 4 Scherle Peggy PRLD Common Stock S - Sale D 37.0761 -607 -23 172,920
2021-08-30 2021-08-27 4 Scherle Peggy PRLD Common Stock S - Sale D 36.2340 -2,707 -98 173,527
2021-08-30 2021-08-27 4 Scherle Peggy PRLD Common Stock S - Sale D 35.3247 -2,700 -95 176,234
2021-08-30 2021-08-27 4 Scherle Peggy PRLD Common Stock M - Exercise D 1.4300 6,014 9 178,934
2021-08-30 2021-08-26 4 Scherle Peggy PRLD Employee Stock Option (Right to Buy) M - Exercise D 1.43 -1,700 33,032
2021-08-30 2021-08-26 4 Scherle Peggy PRLD Common Stock S - Sale D 35.1879 -1,700 -60 172,920
2021-08-30 2021-08-26 4 Scherle Peggy PRLD Common Stock M - Exercise D 1.4300 1,700 2 174,620
2021-08-27 2021-08-25 4 Piper Brian PRLD Employee Stock Option (Right to Buy) M - Exercise D 1.89 -8,333 264,329
2021-08-27 2021-08-25 4 Piper Brian PRLD Common Stock S - Sale D 34.3299 -2,344 -80 0
2021-08-27 2021-08-25 4 Piper Brian PRLD Common Stock S - Sale D 33.2308 -3,889 -129 2,344
2021-08-27 2021-08-25 4 Piper Brian PRLD Common Stock S - Sale D 32.4398 -2,100 -68 6,233
2021-08-27 2021-08-25 4 Piper Brian PRLD Common Stock M - Exercise D 1.8900 8,333 16 8,333
2021-08-17 2021-08-13 4 Scherle Peggy PRLD Employee Stock Option (Right to Buy) M - Exercise D 1.43 -1,728 34,732
2021-08-17 2021-08-13 4 Scherle Peggy PRLD Employee Stock Option (Right to Buy) M - Exercise D 1.89 -558 42,672
2021-08-17 2021-08-13 4 Scherle Peggy PRLD Common Stock S - Sale D 35.0662 -2,286 -80 172,920
2021-08-17 2021-08-13 4 Scherle Peggy PRLD Common Stock M - Exercise D 1.4300 1,728 2 175,206
2021-08-17 2021-08-13 4 Scherle Peggy PRLD Common Stock M - Exercise D 1.8900 558 1 173,478
2021-08-09 2021-08-05 4 Mauro David J PRLD Employee Stock Option (Right to Buy) M - Exercise D 1.89 -15,000 167,610
2021-08-09 2021-08-05 4 Mauro David J PRLD Common Stock S - Sale D 32.6300 -100 -3 0
2021-08-09 2021-08-05 4 Mauro David J PRLD Common Stock S - Sale D 32.1457 -6,721 -216 100
2021-08-09 2021-08-05 4 Mauro David J PRLD Common Stock S - Sale D 31.0278 -2,063 -64 6,821
2021-08-09 2021-08-05 4 Mauro David J PRLD Common Stock S - Sale D 29.9329 -6,116 -183 8,884
2021-08-09 2021-08-05 4 Mauro David J PRLD Common Stock M - Exercise D 1.8900 15,000 28 15,000
2021-07-29 2021-07-27 4 Scherle Peggy PRLD Employee Stock Option (Right to Buy) M - Exercise D 1.43 -20,000 36,460
2021-07-29 2021-07-27 4 Scherle Peggy PRLD Common Stock S - Sale D 36.0882 -680 -25 172,920
2021-07-29 2021-07-27 4 Scherle Peggy PRLD Common Stock S - Sale D 35.4472 -19,320 -685 173,600
2021-07-29 2021-07-27 4 Scherle Peggy PRLD Common Stock M - Exercise D 1.4300 20,000 29 192,920
2021-07-22 2021-07-20 4 Scherle Peggy PRLD Employee Stock Option (Right to Buy) A - Award D 31.23 95,000 95,000
2021-07-22 2021-07-20 4 Vaddi Krishna PRLD Employee Stock Option (Right to Buy) A - Award D 31.23 285,800 285,800
2021-07-22 2021-07-20 4 Morosini Deborah PRLD Employee Stock Option (Right to Buy) A - Award D 31.23 85,000 85,000
2021-07-22 2021-07-20 4 Mauro David J PRLD Employee Stock Option (Right to Buy) A - Award D 31.23 95,000 95,000
2021-07-22 2021-07-20 4 Pierce Christopher PRLD Employee Stock Option (Right to Buy) A - Award D 31.23 85,000 85,000
2021-07-22 2021-07-20 4 Piper Brian PRLD Employee Stock Option (Right to Buy) A - Award D 31.23 115,650 115,650
2021-07-22 2021-07-20 4 Combs Andrew PRLD Employee Stock Option (Right to Buy) A - Award D 31.23 95,000 95,000
2021-07-20 2021-07-19 4 Babler Martin PRLD Employee Stock Option (Right to Buy) A - Award D 31.37 36,400 36,400
2021-07-08 2021-07-06 4 Mauro David J PRLD Employee Stock Option (Right to Buy) M - Exercise D 1.89 -15,000 182,610
2021-07-08 2021-07-06 4 Mauro David J PRLD Common Stock S - Sale D 28.8433 -300 -9 0
2021-07-08 2021-07-06 4 Mauro David J PRLD Common Stock S - Sale D 28.1343 -4,255 -120 300
2021-07-08 2021-07-06 4 Mauro David J PRLD Common Stock S - Sale D 27.1654 -10,445 -284 4,555
2021-07-08 2021-07-06 4 Mauro David J PRLD Common Stock M - Exercise D 1.8900 15,000 28 15,000
2021-06-22 2021-06-18 4 Sandor Victor PRLD Director Stock Option (Right to Buy) A - Award D 31.02 23,344 23,344
2021-06-22 2021-06-18 4 FRIEDMAN PAUL A PRLD Director Stock Option (Right to Buy) A - Award D 31.02 23,344 23,344
2021-06-22 2021-06-18 4 Dier Mardi PRLD Director Stock Option (Right to Buy) A - Award D 31.02 23,344 23,344
2021-06-22 2021-06-18 4 Bonita David P PRLD Director Stock Option (Right to Buy) A - Award D 31.02 23,344 23,344
2021-06-22 2021-06-18 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Qualified Stock Options (right to buy) A - Award I 31.02 23,344 23,344
2021-06-09 2021-06-07 4 Mauro David J PRLD Common Stock M - Exercise D 1.89 -15,000 197,610
2021-06-09 2021-06-07 4 Mauro David J PRLD Common Stock S - Sale D 32.7295 -12,700 -416 0
2021-06-09 2021-06-07 4 Mauro David J PRLD Common Stock S - Sale D 31.6244 -900 -28 12,700
2021-06-09 2021-06-07 4 Mauro David J PRLD Common Stock S - Sale D 30.3541 -1,400 -42 13,600
2021-06-09 2021-06-07 4 Mauro David J PRLD Common Stock M - Exercise D 1.8900 15,000 28 15,000
2021-05-27 2021-05-25 4 Piper Brian PRLD Employee Stock Option (Right to Buy) M - Exercise D 1.89 -8,333 272,662
2021-05-27 2021-05-25 4 Piper Brian PRLD Common Stock S - Sale D 36.0930 -399 -14 0
2021-05-27 2021-05-25 4 Piper Brian PRLD Common Stock S - Sale D 35.4469 -1,736 -62 399
2021-05-27 2021-05-25 4 Piper Brian PRLD Common Stock S - Sale D 34.1119 -3,088 -105 2,135
2021-05-27 2021-05-25 4 Piper Brian PRLD Common Stock S - Sale D 33.5250 -3,110 -104 5,223
2021-05-27 2021-05-25 4 Piper Brian PRLD Common Stock M - Exercise D 1.8900 8,333 16 8,333
2021-05-11 2021-05-07 4 Scherle Peggy PRLD Employee Stock Option (right to buy) M - Exercise D 1.43 -10,000 56,460
2021-05-11 2021-05-07 4 Scherle Peggy PRLD Common Stock S - Sale D 41.8500 -200 -8 172,920
2021-05-11 2021-05-07 4 Scherle Peggy PRLD Common Stock S - Sale D 41.1395 -5,836 -240 173,120
2021-05-11 2021-05-07 4 Scherle Peggy PRLD Common Stock S - Sale D 40.2957 -3,964 -160 178,956
2021-05-11 2021-05-07 4 Scherle Peggy PRLD Common Stock M - Exercise D 1.4300 10,000 14 182,920
2021-05-10 2021-05-05 4 Mauro David J PRLD Common Stock M - Exercise D 1.89 -15,000 212,610
2021-05-10 2021-05-05 4 Mauro David J PRLD Common Stock S - Sale D 41.0682 -1,109 -46 0
2021-05-10 2021-05-05 4 Mauro David J PRLD Common Stock S - Sale D 40.2967 -10,476 -422 1,109
2021-05-10 2021-05-05 4 Mauro David J PRLD Common Stock S - Sale D 39.3555 -3,415 -134 11,585
2021-05-10 2021-05-05 4 Mauro David J PRLD Common Stock M - Exercise D 1.8900 15,000 28 15,000
2021-04-30 2021-04-29 4 Pierce Christopher PRLD Employee Stock Option (right to buy) M - Exercise D 1.89 -3,295 4,323
2021-04-30 2021-04-29 4 Pierce Christopher PRLD Common Stock S - Sale D 40.2928 -3,295 -133 3,750
2021-04-30 2021-04-29 4 Pierce Christopher PRLD Common Stock M - Exercise D 1.8900 3,295 6 7,045
2021-04-30 2021-04-29 4 Morosini Deborah PRLD Employee Stock Option (right to buy) M - Exercise D 1.89 -3,223 4,323
2021-04-30 2021-04-29 4 Morosini Deborah PRLD Common Stock S - Sale D 40.2896 -3,223 -130 444
2021-04-30 2021-04-29 4 Morosini Deborah PRLD Common Stock M - Exercise D 1.8900 3,223 6 3,667
2021-04-29 2021-04-27 4 Mauro David J PRLD Employee Stock Option (right to buy) M - Exercise D 1.89 -25,000 227,610
2021-04-29 2021-04-27 4 Mauro David J PRLD Common Stock S - Sale D 36.1137 -1,711 -62 0
2021-04-29 2021-04-27 4 Mauro David J PRLD Common Stock S - Sale D 35.6759 -15,601 -557 1,711
2021-04-29 2021-04-27 4 Mauro David J PRLD Common Stock S - Sale D 34.6615 -7,688 -266 17,312
2021-04-29 2021-04-27 4 Mauro David J PRLD Common Stock M - Exercise D 1.8900 25,000 47 25,000
2021-04-21 2021-04-19 4 Mauro David J PRLD Employee Stock Option (right to buy) M - Exercise D 1.89 -25,000 252,610
2021-04-21 2021-04-19 4 Mauro David J PRLD Common Stock S - Sale D 31.2692 -4,000 -125 0
2021-04-21 2021-04-19 4 Mauro David J PRLD Common Stock S - Sale D 30.8225 -21,000 -647 4,000
2021-04-21 2021-04-19 4 Mauro David J PRLD Common Stock M - Exercise D 1.8900 25,000 47 25,000
2021-04-15 2021-04-08 4 Scherle Peggy PRLD Employee Stock Option (right to buy) M - Exercise D 1.43 -4,630 66,460
2021-04-15 2021-04-08 4 Scherle Peggy PRLD Common Stock S - Sale D 39.5688 -1,669 -66 172,920
2021-04-15 2021-04-08 4 Scherle Peggy PRLD Common Stock S - Sale D 38.9726 -669 -26 174,589
2021-04-15 2021-04-08 4 Scherle Peggy PRLD Common Stock S - Sale D 37.7182 -875 -33 175,258
2021-04-15 2021-04-08 4 Scherle Peggy PRLD Common Stock S - Sale D 36.9707 -1,417 -52 176,133
2021-04-15 2021-04-08 4 Scherle Peggy PRLD Common Stock A - Award D 1.4300 4,630 7 177,550
2021-04-15 2021-04-08 4 Pierce Christopher PRLD Employee Stock Option (right to buy) M - Exercise D 1.89 -200 7,618
2021-04-15 2021-04-08 4 Pierce Christopher PRLD Common Stock S - Sale D 40.0000 -200 -8 3,750
2021-04-15 2021-04-08 4 Pierce Christopher PRLD Common Stock A - Award D 1.8900 200 0 3,950
2021-04-15 2021-04-08 4 Morosini Deborah PRLD Employee Stock Option (right to buy) M - Exercise D 1.89 -100 7,546
2021-04-15 2021-04-08 4 Morosini Deborah PRLD Common Stock S - Sale D 40.0000 -100 -4 444
2021-04-15 2021-04-08 4 Morosini Deborah PRLD Common Stock M - Exercise D 1.8900 100 0 544
2021-04-15 2021-04-08 4 Mauro David J PRLD Employee Stock Option (right to buy) M - Exercise D 1.89 -9,617 277,610
2021-04-15 2021-04-08 4 Mauro David J PRLD Common Stock S - Sale D 39.5584 -3,549 -140 0
2021-04-15 2021-04-08 4 Mauro David J PRLD Common Stock S - Sale D 38.9972 -1,293 -50 3,549
2021-04-15 2021-04-08 4 Mauro David J PRLD Common Stock S - Sale D 37.8283 -1,501 -57 4,842
2021-04-15 2021-04-08 4 Mauro David J PRLD Common Stock S - Sale D 37.0360 -3,274 -121 6,343
2021-04-15 2021-04-08 4 Mauro David J PRLD Common Stock M - Exercise D 1.8900 9,617 18 9,617
2021-04-09 2021-04-07 4 Scherle Peggy PRLD Employee Stock Option (right to buy) M - Exercise D 1.43 -15,370 71,090
2021-04-09 2021-04-07 4 Scherle Peggy PRLD Common Stock S - Sale D 40.3000 -200 -8 172,920
2021-04-09 2021-04-07 4 Scherle Peggy PRLD Common Stock S - Sale D 39.6278 -6,881 -273 173,120
2021-04-09 2021-04-07 4 Scherle Peggy PRLD Common Stock S - Sale D 39.0162 -8,289 -323 180,001
2021-04-09 2021-04-07 4 Scherle Peggy PRLD Common Stock A - Award D 1.4300 15,370 22 188,290
2021-04-09 2021-04-07 4 Pierce Christopher PRLD Employee Stock Option (right to buy) M - Exercise D 1.89 -828 7,818
2021-04-09 2021-04-07 4 Pierce Christopher PRLD Common Stock S - Sale D 40.0826 -828 -33 3,750
2021-04-09 2021-04-07 4 Pierce Christopher PRLD Common Stock A - Award D 1.8900 828 2 4,578
2021-04-09 2021-04-07 4 Morosini Deborah PRLD Employee Stock Option (right to buy) M - Exercise D 1.89 -1,000 7,646
2021-04-09 2021-04-07 4 Morosini Deborah PRLD Common Stock S - Sale D 40.0430 -1,000 -40 444
2021-04-09 2021-04-07 4 Morosini Deborah PRLD Common Stock M - Exercise D 1.8900 1,000 2 1,444
2021-04-09 2021-04-07 4 Mauro David J PRLD Employee Stock Option (right to buy) M - Exercise D 1.89 -15,383 287,227
2021-04-09 2021-04-07 4 Mauro David J PRLD Common Stock S - Sale D 39.6888 -7,083 -281 0
2021-04-09 2021-04-07 4 Mauro David J PRLD Common Stock S - Sale D 39.0250 -8,300 -324 7,083
2021-04-09 2021-04-07 4 Mauro David J PRLD Common Stock M - Exercise D 1.8900 15,383 29 15,383
2021-01-29 2021-01-27 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Qualified Stock Options (right to buy) M - Exercise I 12.85 -5,188 41,500
2021-01-29 2021-01-27 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Qualified Stock Options (right to buy) M - Exercise I 12.85 -5,188 41,500
2021-01-29 2021-01-27 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock M - Exercise I 12.8500 5,188 67 9,252,951
2021-01-29 2021-01-27 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock M - Exercise I 12.8500 5,188 67 9,252,951
2021-01-13 2021-01-11 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Voting Common Stock P - Purchase I 60.0000 154,222 9,253 5,212,371
2021-01-13 2021-01-11 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Voting Common Stock P - Purchase I 60.0000 12,444 747 509,480
2021-01-12 2021-01-11 4 ORBIMED ADVISORS LLC See Footnotes PRLD Non-Voting Common Stock P - Purchase I 60.0000 41,700 2,502 5,596,886
2021-01-12 2021-01-11 4 Bonita David P See Footnotes PRLD Non-Voting Common Stock P - Purchase I 60.0000 41,700 2,502 5,596,886
2020-09-30 2020-08-21 4/A ORBIMED ADVISORS LLC PRLD Series C Preferred Stock P - Purchase I 1,033,084 1,033,084
2020-09-30 2020-03-27 4/A ORBIMED ADVISORS LLC PRLD Series B Preferred Stock P - Purchase I 3,681,822 7,363,644
2020-09-30 2020-09-29 4 FRIEDMAN PAUL A PRLD Series B Preferred Stock C - Conversion D -152,576 0
2020-09-30 2020-09-29 4 FRIEDMAN PAUL A PRLD Series A Preferred Stock C - Conversion D -295,794 0
2020-09-30 2020-09-29 4 FRIEDMAN PAUL A PRLD Common Stock C - Conversion D 152,576 500,098
2020-09-30 2020-09-29 4 FRIEDMAN PAUL A PRLD Common Stock C - Conversion D 295,794 347,522
2020-09-30 2020-03-27 4 FRIEDMAN PAUL A PRLD Series B Preferred Stock P - Purchase D 76,288 152,576
2020-09-30 2020-09-29 4 Bonita David P PRLD Non-Voting Common Stock C - Conversion I 5,555,186 5,555,186
2020-09-30 2020-09-29 4 Bonita David P PRLD Series C Preferred Stock C - Conversion I -413,234 0
2020-09-30 2020-09-29 4 Bonita David P PRLD Series C Preferred Stock C - Conversion I -619,850 0
2020-09-30 2020-09-29 4 Bonita David P PRLD Series B Preferred Stock C - Conversion I -2,945,458 0
2020-09-30 2020-09-29 4 Bonita David P PRLD Series B Preferred Stock C - Conversion I -4,418,186 0
2020-09-30 2020-09-29 4 Bonita David P PRLD Series A Preferred Stock C - Conversion I -2,196,494 0
2020-09-30 2020-09-29 4 Bonita David P PRLD Series A Preferred Stock C - Conversion I -3,294,743 0
2020-09-30 2020-09-29 4 Bonita David P PRLD Common Stock C - Conversion I 8,332,779 9,250,191
2020-09-30 2020-09-25 4 Bonita David P PRLD Common Stock P - Purchase I 19.0000 710,500 13,500 917,412
2020-09-30 2020-09-25 4 Bonita David P PRLD Common Stock P - Purchase I 19.0000 526,300 10,000 526,300
2020-09-30 2020-09-24 4 Bonita David P PRLD Director Stock Option (right to buy) A - Award D 12.85 46,688 46,688
2020-09-30 2020-08-21 4 Bonita David P PRLD Series C Preferred Stock P - Purchase I 1,033,084 1,033,084
2020-09-30 2020-03-27 4 Bonita David P PRLD Series B Preferred Stock P - Purchase I 3,681,822 7,363,644
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Voting Common Stock C - Conversion I 382,884 5,058,149
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series C Convertible Preferred Stock C - Conversion I -382,884 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Voting Common Stock C - Conversion I 30,349 497,036
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series C Convertible Preferred Stock C - Conversion I -30,349 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series C Convertible Preferred Stock C - Conversion I -574,327 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series C Convertible Preferred Stock C - Conversion I -45,524 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Voting Common Stock C - Conversion I 2,698,424 4,675,265
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series B Convertible Preferred Stock C - Conversion I -2,698,424 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Voting Common Stock C - Conversion I 247,034 466,687
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series B Convertible Preferred Stock C - Conversion I -247,034 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series B Convertible Preferred Stock C - Conversion I -4,047,634 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series B Convertible Preferred Stock C - Conversion I -370,552 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Voting Common Stock C - Conversion I 1,976,841 1,976,841
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series A Convertible Preferred Stock C - Conversion I -1,976,841 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Voting Common Stock C - Conversion I 219,653 219,653
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series A Convertible Preferred Stock C - Conversion I -219,653 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series A Convertible Preferred Stock C - Conversion I -2,965,263 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series A Convertible Preferred Stock C - Conversion I -329,478 0
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock P - Purchase I 19.0000 1,474,319 28,012 9,247,763
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock P - Purchase I 19.0000 104,628 1,988 870,873
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock C - Conversion I 574,327 7,773,444
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock C - Conversion I 45,524 766,245
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock C - Conversion I 4,047,634 7,199,117
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock C - Conversion I 370,552 720,721
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock C - Conversion I 2,965,263 3,151,483
2020-09-30 2020-09-29 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Common Stock C - Conversion I 329,478 350,169
2020-09-30 2020-09-24 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Non-Qualified Stock Option (right to buy) A - Award I 12.85 46,688 46,688
2020-09-30 2020-08-21 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series C Preferred Stock P - Purchase I 14.5196 957,211 13,898 957,211
2020-09-30 2020-08-21 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series C Preferred Stock P - Purchase I 14.5196 75,873 1,102 75,873
2020-09-30 2020-03-27 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series B Preferred Stock P - Purchase I 3.9324 3,373,029 13,264 3,373,029
2020-09-30 2020-03-27 4 BAKER BROS. ADVISORS LP See Footnotes PRLD Series B Preferred Stock P - Purchase I 3.9324 308,793 1,214 308,793
2020-09-29 2020-09-29 4 Combs Andrew PRLD Common Stock P - Purchase D 19.0000 1,000 19 260,380
2020-09-29 2020-09-29 4 Vaddi Krishna By Trust PRLD Series A Preferred Stock C - Conversion I -32,876 0
2020-09-29 2020-09-29 4 Vaddi Krishna By Trust PRLD Series A Preferred Stock C - Conversion I -32,876 0
2020-09-29 2020-09-29 4 Vaddi Krishna PRLD Series A Preferred Stock C - Conversion I -101,477 0
2020-09-29 2020-09-29 4 Vaddi Krishna By Trust PRLD Common Stock C - Conversion I 32,876 551,774
2020-09-29 2020-09-29 4 Vaddi Krishna By Trust PRLD Common Stock C - Conversion I 32,876 551,774
2020-09-29 2020-09-29 4 Vaddi Krishna PRLD Common Stock C - Conversion I 101,477 101,477
2020-09-29 2020-09-29 4 Pierce Christopher PRLD Common Stock P - Purchase D 19.0000 3,750 71 3,750
2020-09-29 2020-09-29 4 Morosini Deborah PRLD Common Stock P - Purchase D 19.0000 444 8 444
2020-09-29 2020-09-29 4 Dier Mardi PRLD Common Stock P - Purchase D 19.0000 10,000 190 10,000
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PRLD Non-Voting Common Stock C - Conversion I 5,555,186 5,555,186
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PRLD Series C Preferred Stock C - Conversion I -413,234 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PRLD Series C Preferred Stock C - Conversion I -619,850 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PRLD Series B Preferred Stock C - Conversion I -2,945,458 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PRLD Series B Preferred Stock C - Conversion I -4,418,186 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PRLD Series A Prefered Stock C - Conversion I -2,196,494 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PRLD Series A Preferred Stock C - Conversion I -3,294,743 0
2020-09-29 2020-09-29 4 ORBIMED ADVISORS LLC PRLD Common Stock C - Conversion I 8,332,779 9,250,191
2020-09-29 2020-09-25 4 ORBIMED ADVISORS LLC PRLD Common Stock P - Purchase I 19.0000 710,500 13,500 917,412
2020-09-29 2020-09-25 4 ORBIMED ADVISORS LLC PRLD Common Stock P - Purchase I 19.0000 526,300 10,000 526,300
2020-09-28 2020-09-24 4 Sandor Victor PRLD Director Stock Option (right to buy) A - Award D 19.00 3,458 3,458
2020-09-28 2020-09-24 4 Dier Mardi PRLD Director Stock Option (right to buy) A - Award D 19.00 3,458 3,458
2020-09-24 3 Scherle Peggy PRLD Common Stock D 172,920
2020-09-24 3 BAKER JULIAN PRLD Common Stock I 186,220
2020-09-24 3 BAKER JULIAN PRLD Common Stock I 20,691
2020-09-24 3 Vaddi Krishna By Trust PRLD Common Stock I 423,655
2020-09-24 3 Vaddi Krishna PRLD Common Stock D 1,045,519
2020-09-24 3 Vaddi Krishna By Trust PRLD Common Stock I 518,898
2020-09-24 3 Vaddi Krishna By Trust PRLD Common Stock I 518,900
2020-09-24 3 OrbiMed Capital GP VI LLC PRLD Common Stock I 206,912
2020-09-24 3 FRIEDMAN PAUL A PRLD Common Stock D 51,728
2020-09-24 3 Combs Andrew PRLD Common Stock D 259,380
2020-09-24 3 Bonita David P See footnotes PRLD Common Stock I 206,912
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista